Position in GILD
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$92,810,627
-$9,138,109 QoQ
Shares Held
734,610
+0.4% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
2.93%
of 13F equity value
Holder Rank
#152
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAILARD, INC. holds $201,504,836 across 13 Drug Manufacturers - General names. GILD ranks #1 (46.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
734,610 | $92,810,627 | |
| 2 | JNJ |
Johnson & Johnson
|
147,802 | $37,537,273 | |
| 3 | AMGN |
Amgen Inc
|
49,586 | $17,956,082 | |
| 4 | LLY |
ELI LILLY & Co
|
13,510 | $16,204,300 | |
| 5 | ABBV |
AbbVie Inc.
|
55,207 | $13,892,289 | |
| 6 | AZN |
Astrazeneca PLC
|
70,691 | $13,404,427 | |
| 7 | MRK |
Merck & Co., Inc.
|
26,669 | $3,426,966 | |
| 8 | NVS |
Novartis AG
|
13,869 | $2,173,549 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,810,627 | 734,610 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $101,948,736 | 731,497 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $90,098,156 | 734,057 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $74,259,111 | 669,001 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $73,844,409 | 666,045 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $74,637,401 | 666,108 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $62,156,604 | 672,909 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $56,403,527 | 672,752 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $46,152,368 | 672,677 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $49,270,953 | 672,641 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $54,560,802 | 673,507 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $54,132,534 | 722,345 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $605,076 | 7,851 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $720,179 | 8,680 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $756,424 | 8,811 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $660,576 | 10,708 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $582,002 | 9,416 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $544,799 | 9,164 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $715,644 | 9,856 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $729,513 | 10,444 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $583,588 | 8,475 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $892,152 | 13,804 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $840,691 | 14,430 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $780,396 | 12,350 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $822,719 | 10,693 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $5,242,694 | 70,127 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||